✦ LIBER ✦

Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia

✍ Scribed by Huan Chen, Kai-yan Liu, Lan-ping Xu, Dai-hong Liu, Yu-hong Chen, Xiang-yu Zhao, Wei Han, Xiao-hui Zhang, Yu Wang, Yuan-yuan Zhang, Ya-zhen Qin, Yan-rong Liu, Xiao-jun Huang

Book ID: 119913619
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 287 KB
Volume: 5
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-5-29

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Case of a patient with Philadelphia-chro

Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions

✍ Makoto Yoshimitsu; Hiroshi Fujiwara; Atsuo Ozaki; Heiichiro Hamada; Kakushi Mats 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 163 KB

Prophylactic impact of imatinib administ

Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia

✍ Takasaki, H; Nakaseko, C; Sakura, T; Fujisawa, S; Yokota, A; Yano, S; Usuki, K; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 207 KB

A potential graft-versus-leukemia effect

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

✍ Espérou, H; Boiron, J-M; Cayuela, J-M; Blanchet, O; Kuentz, M; Jouet, J-P; Milpi 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 183 KB

Successful Treatment of Minimal Residual

Successful Treatment of Minimal Residual Disease—Positive Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia with Imatinib Followed by Reduced-Intensity Unrelated Cord Blood Transplantation after Allogeneic Peripheral Blood Stem Cell Transplantation

✍ Akiyoshi Takami; Shigeru Shimadoi; Chiharu Sugimori; Kenichi Takemoto; Masami Sh 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 92 KB

Long-Term Follow-up of Allogeneic Hemato

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes

✍ Partow Kebriaei; Rima Saliba; Gabriela Rondon; Alexandre Chiattone; Rajyalakshmi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 237 KB

The extent of minimal residual disease r

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af